Johnson & Johnson has expanded their recall of over-the-counter drugs. That makes the second recall in less than a month.
The list now includes certain batches of regular and extra-strength Tylenol, children’s Tylenol, eight-hour Tylenol, Tylenol arthritis, Tylenol PM, children’s Motrin, Motrin IB, Benadryl Rolaids, Simply Sleep, and St. Joseph’s aspirin.
Caplet and geltab products sold in the Americas, the United Arab Emirates, and Fiji were also recalled.
The recall is because of a moldy smell that has reportedly made a handful of customers ill.
Johnson & Johnson says the smell originated in a plant in Puerto Rico and that cause of the problem was a chemical used in the treatment of wooden shipping pallets.
The company has stopped using these contaminated pallets and has asked their suppliers to do the same.
Johnson & Johnson has asked these other companies to stop. Not refused to accept anything shipped on these pallets. Proving that the bottom line with anything Johnson & Johnson -or any other big company- does is their bottom line.
The PR damage is important, but the 70 customers affected is such a minute number that losing them and paying to settle the inevitable lawsuit won’t even appear in their annual report to the stockholders.
Meanwhile the FDA has criticized the Johnson & Johnson for a slow investigation, saying the company has known about this problem since 2008.
This statement from the company tells what it takes to get them to do something: “McNeil Consumer Healthcare has received an FDA form 483 dated Jan. 8, 2010, and is actively working with the FDA to address their concerns.”
For more on the recall click here.




